- Correspondence to: Dr B Choi Centre for Chronic Disease Prevention and Control (CCDPC), Public Health Agency of Canada (PHAC), Government of Canada, AL no 6701A, 120 Colonnade Road, Ottawa, Ontario K1A 1B4, Canada;
- Accepted July 20, 2005
- First published November 14, 2005.
In our March 2006 issue, Oscar H. Franco and colleagues discussed the concept of a fixed-dose combination pill, which was referred to as a polypill, a theoretical combination of six pharmacological compounds for the treatment of cardiovascular disease proposed by N.J. Wald and M.R. Law in their article "A strategy to reduce cardiovascular disease by more than 80%" (BMJ 2003;326:1419). We would like to make it clear that Franco et al's article was a discussion on the theoretical concept of a fixed-does combination pill as proposed in Wald and Law's article and did not intend in any way to refer to the POLYPILL, a term which is currently the subject of trade mark applications by Professor Wald in the USA and Canada. The Editors wish to apologise to Professor Wald for any ambiguity that may have occurred in the wording of this article.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.